II. Epidemiology
- Risk in Asplenic or Hyposplenic patients
- Hospitalization for infection in 33% within 10 years
- Highest risk in first 2 years after splenectomy
III. Causes
- Most common
- Streptococcus Pneumoniae (57%)
- HaemophilusInfluenzae (6%)
- Neisseria Meningitidis (3.7%)
- Salmonella (esp. in Sickle Cell Anemia)
- Other causes
- Capnocytophaga canimorsus (dog exposure)
- Group B Streptococcus
- Bartonella Bacilliformis
- Eikenella corrodens
- Region specific (tick-borne illness)
IV. Risk Factors in Asplenic or Hyposplenic patients
- Splenectomy within last 2 years (highest risk)
- Hodgkin's Disease
- Hypogammaglobulinemia
- Chemotherapy
- Radiation Therapy
- Bone Marrow Transplantation
V. Symptoms
VI. Signs
- Septic Shock
- Disseminated Intravascular Coagulation
- May be rapidly fatal within 48 hours
VII. Labs (do not delay Antibiotics)
- Chemistry panel (Chem7 or SMA7)
-
Complete Blood Count with Platelets and differential
- White Blood Cell Count will be abnormal (too high or too low)
- Toxic granulation
- Thrombocytopenia
-
Peripheral Blood Smear with buffy coat preparation
- Observe for Bacteria
- Blood Cultures
- Urinalysis and Urine Culture
VIII. Imaging
IX. Management: Antibiotics
- See Sepsis
- Empirically cover Penicillin-resistant pneumococcus and HaemophilusInfluenzae
- First Line Antibiotics (usually used in combination with Vancomycin)
- Cefotaxime (Claforan)
- Adults: 2 g IV q8 hours
- Children: 25 to 50 mg/kg IV q6 hours
- Ceftriaxone (Rocephin)
- Adults: 2 g IV q12 to 24 hours
- Children: 50 mg/kg IV q12 hours
- Levofloxacin (Use as alternative only if Anaphylaxis to Penicillin or Cephalosporins)
- Adults: 750 mg IV q24 hours
- Cefotaxime (Claforan)
- Added Antibiotics in Special Circumstances
- Penicillin Resistant Pneumococcus suspected (add in most cases)
- Vancomycin
- Adults: 1 to 1.5 g IV q12 hours
- Children: 30 mg/kg IV q12 hours
- Vancomycin
- Gastrointestinal or Urinary Source
- Gentamicin
- Adults: 5 to 7 mg/kg IV q24 hours
- Children: 2.5 mg/kg IV q8 hours
- Ciprofloxacin (adults only) 400 mg IV q12 hours
- Gentamicin
- Penicillin Resistant Pneumococcus suspected (add in most cases)
X. Prognosis
- Mortality
- Immediate treatment: 10% mortality
- Delayed treatment: 50-80% mortality
XI. Prevention
- See Asplenic
XII. References
- Brigden (2001) Am Fam Physician 63(3):499-506 [PubMed]
- Brigden (1999) Crit Care Med 27:836-42 [PubMed]
- Sinwar (2014) Int J Surg 12(12): 1314-6 [PubMed]
- Tahir (2020) Cureus 12(2): e6898 +PMID:32195065 [PubMed]
- Hansen (2001) Pediatr Dev Pathol 4(2):105-21 [PubMed]
- Lynch (1996) Infect Dis Clin North Am 10:693-707 [PubMed]